CRISPR Therapeutics AG (CRSP) FCF Margin (2016 - 2025)
Historic FCF Margin for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q4 2025 value amounting to 10771.99%.
- CRISPR Therapeutics AG's FCF Margin fell 106311000.0% to 10771.99% in Q4 2025 from the same period last year, while for Dec 2025 it was 9855.5%, marking a year-over-year decrease of 94677800.0%. This contributed to the annual value of 9855.5% for FY2025, which is 94677800.0% down from last year.
- According to the latest figures from Q4 2025, CRISPR Therapeutics AG's FCF Margin is 10771.99%, which was down 106311000.0% from 9528.46% recorded in Q3 2025.
- In the past 5 years, CRISPR Therapeutics AG's FCF Margin registered a high of 21633.13% during Q1 2024, and its lowest value of 1991983.33% during Q4 2022.
- Over the past 5 years, CRISPR Therapeutics AG's median FCF Margin value was 10771.99% (recorded in 2025), while the average stood at 121690.58%.
- Per our database at Business Quant, CRISPR Therapeutics AG's FCF Margin tumbled by 2000000000bps in 2022 and then skyrocketed by 2000000000bps in 2023.
- Quarter analysis of 5 years shows CRISPR Therapeutics AG's FCF Margin stood at 738.2% in 2021, then crashed by -269742bps to 1991983.33% in 2022, then surged by 100bps to 48.12% in 2023, then plummeted by -193bps to 140.89% in 2024, then plummeted by -7546bps to 10771.99% in 2025.
- Its last three reported values are 10771.99% in Q4 2025, 9528.46% for Q3 2025, and 12779.93% during Q2 2025.